quinoxalines has been researched along with Trypanosomiasis, African in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Agnamey, P; Azas, N; Cohen, A; Daulouede, S; Del Favero, M; Farvacques, N; Guillon, J; Hutter, S; Le Pape, P; MulliƩ, C; Pagniez, F; Pinaud, N; Ronga, L; Savrimoutou, S; Sonnet, P; Soum, C; Vincendeau, P | 1 |
1 other study(ies) available for quinoxalines and Trypanosomiasis, African
Article | Year |
---|---|
Design, synthesis and biological evaluation of novel 4-alkapolyenylpyrrolo[1,2-a]quinoxalines as antileishmanial agents--part III.
Topics: Animals; Cell Proliferation; Dose-Response Relationship, Drug; Drug Design; Female; Hep G2 Cells; Humans; Leishmania; Macrophages; Mice; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Quinoxalines; Structure-Activity Relationship; Trypanocidal Agents; Trypanosoma brucei brucei; Trypanosomiasis, African | 2014 |